Younossi, ZM, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, Tsochatzis, E, Trivikrama, SK, Balakumaran, LK, Fan, JG, Roberts, SK, Alswat, K, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, MG, Chan, WK, Fernandez, MIC, Duseja, A, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Alnaamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapé, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Kim-Jun, K, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Segrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, A, Lombardi, R, Lam, B, Racila, A, Alqahtani, SA, Stepanova, M. Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study. HEPATOLOGY. 2026; 84(1)DOI:10.1097/HEP.0000000000001564. PMID:41100867. IF:15.800(Q1/1D).

Varisco, B, Piovani, D, Del Turco, ER, Bussini, L, Paul, M, Sabik, EF, Castagna, A, Ripa, M, Gomes, MZR, Di Bella, S, Zerbato, V, Lopez, AB, Franceschini, E, Bandera, A, Oliva, A, Gavaruzzi, F, Muñoz, P, Mularoni, A, Seminari, E, Morelli, P, Pocaterra, D, Tascini, C, Papadimitriou-Olivgeris, M, Coppola, N, Cristini, F, Russo, A, Bassetti, M, Travi, G, Lopez-Contreras, J, Viale, P, Cento, V, Diella, L, Bavaro, DF, Gaibani, P, Giannella, M, Bartoletti, M. Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis. CLINICAL MICROBIOLOGY AND INFECTION. 2026; 32(7)DOI:10.1016/j.cmi.2026.02.019. PMID:41748017. IF:8.500(Q1/1D).

Heezen, LG, Mao, QR, Nicolau, S, Rausell, CN, van der Weerd, J, Kueckelhaus, J, Nath, RG, Manera, JD, Kan, HE, Niks, EH, van Putten, M, Aartsma-Rus, A, Flanigan, KM, Mahfouz, A, Spitali, P. Unraveling the spatial landscape of dystrophinopathies: a transcriptomic approach to Becker and Duchenne muscular dystrophies. JOURNAL OF PATHOLOGY. 2026; 269(3)DOI:10.1002/path.70067. PMID:42067897. IF:5.200(Q1/1D).

Pizarro-Galleguillos, B, Verdú-Diaz, J, Gómez-Andrés, D, Tobar, F, Montalba, C, Andia, M, Diaz-Manera, J, Jara, JD, Bevilacqua, JA. Visual mapping of muscle MRI fatty replacement patterns in genetic myopathies using dimensionality reduction. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106464. PMID:42263369. IF:2.800(Q2/5D).

Sabater, L, Guasp, M, García, RR, Rondán, LN, Querol, L, Martín-Aguilar, L, Llarch, P, Balasa, M, Lladó, A, Painous, C, Compta, Y, Serafim, AB, Montini, A, Iranzo, A, Cano, JS, Dalmau, JO, Graus, F, Gaig, C. Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease. Neurology-Neuroimmunology & Neuroinflammation. 2026; 13(4)DOI:10.1212/NXI.0000000000200600. PMID:42241645. IF:7.500(Q1/1D).

Pena-Guzman, L, Bolano-Díaz, C, Lleixà, C, Querol, L, Trainor, C, Suetterlin, K, Straub, V, Díaz-Manera, J. Sensory neuronopathy secondary to gene therapy with AT845 for Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106441. PMID:42142433. IF:2.800(Q2/5D).

Putri, VP, Samarasekera, N, Moullaali, TJ, Jampana, S, Aked, J, Åsberg, S, Schulman, S, Tsivgoulis, G, Pikilidou, M, Tsai, HH, Tsai, LK, Myint, PK, Pana, TA, Cordonnier, C, Casolla, B, Gaist, D, Pezzini, A, Camps-Renom, P, Klijn, CJM, Romoli, M, Tveiten, A, Liu, M, Xu, MM, Wu, B, Werring, D, Nash, PS, Banerjee, G, Li, LX, Salman, RAS. Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis. International Journal of Stroke. 2026; 21(6)DOI:10.1177/17474930261416692. PMID:41605872. IF:8.700(Q1/1D).

Majem, M, Mata, KM, Ibarguren, AM, Poves, MZ, Requena, C, Aparisi, FDA, Carrera, C, Cordellat, AB, Freites-Martinez, A, Sanmartin, O. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology. Clinical & Translational Oncology. 2026; 28(7)DOI:10.1007/s12094-025-04209-0. PMID:41604110. IF:2.500(Q3/6D).